Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Exosome Polyphosphate Mediates the Activation of FXII By Cancer Cell-Derived Exosomes

Dewen You, PhD, Suman Kundu, MBA, Alvin H. Schmaier, MD, Alok A. Khorana, MD, Keith R. McCrae, MD

Blood (2018) 132 (Supplement 1): 3800.

https://doi.org/10.1182/blood-2018-99-117308

Published: 2018

Journal Articles

Newly Identified Metabolites Connect Colon Cancer to Thrombosis

Mostafa Belghasem, MD PhD, Daniel Michael Roth, MSc, BSc, Joshua Aaron Walker, PhD, Sean Richards, Cheryl Spencer, Joseph Yeghishe Tashijan, BSc, Nkriuka Arinze, MD, Chris Andry, MPhil, PhD, Katya Ravid, PhD DSc, Vipul Chitalia, MD PhD

Blood (2018) 132 (Supplement 1): 78.

https://doi.org/10.1182/blood-2018-99-113680

Published: 2018

Journal Articles

Molecular and Pharmacological Inhibition of ATP Binding Cassette Transporter ABCB6 Decreases Chemoresistance in Acute Myeloid Leukemia

Sreeja Karathedath, PhD, Raveen Stephen Stallon Illangeswaran, M.Sc.,, Saswati Das, MSc., Bharathi M Rajamani, Srujan Kumar Marepally, M.Sc., PhD, Partha Kasturi, PhD, Vikram Mathews, MD DM, Shaji Ramachandran Velayudhan, M.Sc., PhD, Poonkuzhali Balasubramanian, MSc, PhD

Blood (2017) 130 (Supplement 1): 1254.

https://doi.org/10.1182/blood.V130.Suppl_1.1254.1254

Published: 2017

Journal Articles

Extracellular Vesicles Derived from HT-29 Colorectal Cancer Cells Induce Endothelial Cell Activation and Procoagulant Activity

Yun Tian, Meifang Wu, MD, Alok A. Khorana, MD, Keith R. McCrae, MD

Blood (2015) 126 (23): 3456.

https://doi.org/10.1182/blood.V126.23.3456.3456

Published: 2015

Journal Articles

A Crispr/Cas9 Drop-out Screen Identifies Genome-Wide Genetic Valnerubilities in Acute Myeloid Leukaemia

Blood (2015) 126 (23): 554.

https://doi.org/10.1182/blood.V126.23.554.554

Published: 2015

Journal Articles

An Fc-Engineered CD133 Antibody for Induction of NK Cell Reactivity Against Cancer Cells

Kathrin Rothfelder, Julia Leibold, Ludger Grosse-Hovest, PhD, Hans-Joerg Buehring, PhD, Gundram Jung, MD, Lothar Kanz, MD, Helmut R Salih, MD

Blood (2014) 124 (21): 2739.

https://doi.org/10.1182/blood.V124.21.2739.2739

Published: 2014

Journal Articles

Proteomic Characterization of An Isogenic Multiple Myeloma Cell Line Model of Bortezomib Resistance

*Catriona A. Hayes, MD, *Paul Dowling, PhD, Joseph Negri, Michael Henry, Leutz Buon, Jana Jakubikova, PhD, Jake E Delmore, Douglas W. McMillin, PhD, Steffen Klippel, PhD, Hannah M. Jacobs, Niels W.C.J. van de Donk, MD, PhD, Eugen Dhimolea, PhD, Panisinee Lawasut, MD, MSc, Paul G. Richardson, MD, Kenneth C. Anderson, MD, Martin Clynes, PhD, *Peter O Gorman, MD, PhD, *Constantine S. Mitsiades, MD, PhD

Blood (2011) 118 (21): 1820.

https://doi.org/10.1182/blood.V118.21.1820.1820

Published: 2011

Journal Articles

Bortezomib-Resistant Cell Lines Have Increased Proteasome Levels but Remain Sensitive to Carfilzomib.

Erika Suzuki, Susan Demo, PhD, Shirin Arastu-Kapur, PhD, Christopher J Kirk, Ph.D, Mark K Bennett, PhD

Blood (2009) 114 (22): 2852.

https://doi.org/10.1182/blood.V114.22.2852.2852

Published: 2009

Journal Articles

Further Preclinical Studies with APR-246, a Novel Anticancer Compound Currently in Clinical Trials for Hematological Malignancies and Prostate Cancer.

Nina Mohell, PhD, Charlotta Liljebris, PhD, Jessica Alfredsson, PhD, Ylva Lindman, MSc, Maria Uustalu, MSc, Klas G Wiman, PhD, MD, Thomas Uhlin, BSc

Blood (2009) 114 (22): 3773.

https://doi.org/10.1182/blood.V114.22.3773.3773

Published: 2009

Journal Articles

In Vitro Preclinical Study Results for a Phase I Adoptive Immunotherapy Trial Using Cetuximab in Association with Allogeneic NK Cell Infusion in KRAS Oncogene Mutated Metastatic Colorectal Cancer Patients.

Elisabetta Todisco, Francesca Re, Donatella Genovese, Ilaria Turin, Lorenza Rimassa, Adalberto Ibatici, Luca Castagna, Armando Santoro, Daniela Montagna

Blood (2009) 114 (22): 5119.

https://doi.org/10.1182/blood.V114.22.5119.5119

Published: 2009

Journal Articles

Interactions of the Mdm2/p53 and Proteasome Pathways: Implications for Combination Strategies to Enhance the Anti-Myeloma Activity of Bortezomib

Melissa G. Ooi, Patrick J. Hayden, Douglas W. McMillin, Joseph M. Negri, Jake Delmore, Noopur S Raje, Nikhil C. Munshi, Dharminder Chauhan, Teru Hideshima, Paul G. Richardson, Constantine S. Mitsiades, Kenneth C Anderson, Nicholas Mitsiades

Blood (2008) 112 (11): 2651.

https://doi.org/10.1182/blood.V112.11.2651.2651

Published: 2008

Journal Articles

Preclinical Pharmacology and in Vitro Characterization of PR-047, An Oral Inhibitor of the 20S Proteasome

Tony Muchamuel, Monette Aujay, Mark K Bennett, PhD, Maya Dajee, Susan Demo, PhD, Christopher J Kirk, Ph.D, Ying Fang, Jing Jiang, M.D., Evan Lewis, Yan Lu, Guy Laidig, Francesco Parlati, PhD, Jamie Shields, Congcong m Sun, Jinfu Yang, Han-Jie Zhou, PhD

Blood (2008) 112 (11): 3671.

https://doi.org/10.1182/blood.V112.11.3671.3671

Published: 2008

Journal Articles

High Frequency of 1p36.32 Deletion or Loss of Heterozygosity in Follicular Lymphoma (FL).

K.-John Cheung, MSc, Adele Telenius, Betty Lai, Nathalie Johnson, MD, Thomas Relander, MD, Christian Steidl, MD, Agnes Baross, PhD, Hong Qian, Jacquie Schein, PhD, Marco Marra, PhD, Joseph M. Connors, MD, Randy D. Gascoyne, MD, Douglas E. Horsman, MD

Blood (2007) 110 (11): 183.

https://doi.org/10.1182/blood.V110.11.183.183

Published: 2007

Journal Articles

ARRY-429520, a KSP Inhibitor with Efficacy in Animal Models of Solid and Liquid Tumors.

Rich Woessner, PhD, Chris Corrette, Ph.D., Shelley Allen, Ph.D., Jeremy Hans, Ph.D., Qian Zhao, Ph.D., Tom Aicher, Ph.D., Joe Lyssikatos, Ph.D., John Robinson, Ph.D., Greg Poch, Ph.D., Laura Hayter, A.S., April Cox, M.S., Patrice Lee, Ph.D., James Winkler, Ph.D., Kevin Koch, Ph.D., Eli Wallace, Ph.D.

Blood (2006) 108 (11): 4388.

https://doi.org/10.1182/blood.V108.11.4388.4388

Published: 2006

Journal Articles

dSLIM Immunomodulators Induce Anti-Tumor Responses Both In Vitro and In Vivo .

Manuel Schmidt, Javier de Cristobal, Astrid Sander, Bernadette Brzezicha, Sven A. König Merediz, Burghardt Wittig

Blood (2006) 108 (11): 1727.

https://doi.org/10.1182/blood.V108.11.1727.1727

Published: 2006

Journal Articles

Functional and Antigenic Detection of Intravascular Tissue Factor (TF).

Florian Langer, Ali Amirkhosravi, Brigitte Spath, Hina Desai, Mildred Amaya, Judith Dierlamm, Barbara Eifrig, John L. Francis, Carsten Bokemeyer

Blood (2006) 108 (11): 4002.

https://doi.org/10.1182/blood.V108.11.4002.4002

Published: 2006

Journal Articles

Cycloxygenase-2 (COX-2) Expression Is More in Clonal Plasma Cells.

S. Paneesha, E. Leung, Anton Borg, Peter Rose, Alan G. Morris

Blood (2005) 106 (11): 5103.

https://doi.org/10.1182/blood.V106.11.5103.5103

Published: 2005

Journal Articles

dSLIM Immunomodulators Induce Anti-Tumor Responses Both In Vitro and In Vivo .

Manuel Schmidt, Javier de Cristobal, Astrid Sander, Bernadette Brzezicha, Sven A. Koenig-Merediz, Burghardt Wittig

Blood (2005) 106 (11): 5527.

https://doi.org/10.1182/blood.V106.11.5527.5527

Published: 2005

Journal Articles

Is Cladribine, a Treatment for Chronic Lymphocytic Leukemia, a DNA Methylation Inhibitor?.

Margaret K. Yu, Mark Wade, Brent C. Moore, Frank A. Fitzpatrick

Blood (2004) 104 (11): 4770.

https://doi.org/10.1182/blood.V104.11.4770.4770

Published: 2004

Journal Articles

Cyclooxygenase-2 (COX-2) Is Frequently Expressed in Multiple Myeloma (MM) and Is Associated with Poor Outcome.

Marco Ladetto, Sonia Vallet, Andreas Trojan, Maria Dell’Aquila, Luigia Monitillo, Loredana Santo, Alessandra Bertola, Patrizia Falco, Federica Cavallo, Daniela Drandi, Irene Ricca, Gloria Pagliano, Monica Astolfi, Alberto Rocci, Beata Bode, Antonio Palumbo, Corrado Tarella, Paola Omedé, Mario Boccadoro

Blood (2004) 104 (11): 2450.

https://doi.org/10.1182/blood.V104.11.2450.2450

Published: 2004

NARROW

Exosome Polyphosphate Mediates the Activation of FXII By Cancer Cell-Derived Exosomes

Newly Identified Metabolites Connect Colon Cancer to Thrombosis

Molecular and Pharmacological Inhibition of ATP Binding Cassette Transporter ABCB6 Decreases Chemoresistance in Acute Myeloid Leukemia

Extracellular Vesicles Derived from HT-29 Colorectal Cancer Cells Induce Endothelial Cell Activation and Procoagulant Activity

A Crispr/Cas9 Drop-out Screen Identifies Genome-Wide Genetic Valnerubilities in Acute Myeloid Leukaemia

An Fc-Engineered CD133 Antibody for Induction of NK Cell Reactivity Against Cancer Cells

Proteomic Characterization of An Isogenic Multiple Myeloma Cell Line Model of Bortezomib Resistance

Bortezomib-Resistant Cell Lines Have Increased Proteasome Levels but Remain Sensitive to Carfilzomib.

Further Preclinical Studies with APR-246, a Novel Anticancer Compound Currently in Clinical Trials for Hematological Malignancies and Prostate Cancer.

In Vitro Preclinical Study Results for a Phase I Adoptive Immunotherapy Trial Using Cetuximab in Association with Allogeneic NK Cell Infusion in KRAS Oncogene Mutated Metastatic Colorectal Cancer Patients.

Interactions of the Mdm2/p53 and Proteasome Pathways: Implications for Combination Strategies to Enhance the Anti-Myeloma Activity of Bortezomib

Preclinical Pharmacology and in Vitro Characterization of PR-047, An Oral Inhibitor of the 20S Proteasome

High Frequency of 1p36.32 Deletion or Loss of Heterozygosity in Follicular Lymphoma (FL).

ARRY-429520, a KSP Inhibitor with Efficacy in Animal Models of Solid and Liquid Tumors.

dSLIM Immunomodulators Induce Anti-Tumor Responses Both In Vitro and In Vivo .

Functional and Antigenic Detection of Intravascular Tissue Factor (TF).

Cycloxygenase-2 (COX-2) Expression Is More in Clonal Plasma Cells.

dSLIM Immunomodulators Induce Anti-Tumor Responses Both In Vitro and In Vivo .

Is Cladribine, a Treatment for Chronic Lymphocytic Leukemia, a DNA Methylation Inhibitor?.

Cyclooxygenase-2 (COX-2) Is Frequently Expressed in Multiple Myeloma (MM) and Is Associated with Poor Outcome.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only